| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.008 |